Clinically amyopathic dermatomyositis: analysis of a monocentric cohort
- PMID: 24872214
- DOI: 10.1097/CND.0000000000000038
Clinically amyopathic dermatomyositis: analysis of a monocentric cohort
Abstract
Objective: Clinically amyopathic dermatomyositis (CADM) is characterized by the presence of specific cutaneous manifestations of dermatomyositis (DM) without clinical signs of muscular involvement. The aim of this study was to examine the prevalence, clinical characteristics, and outcome of patients with CADM followed at our Rheumatology Unit.
Methods: Clinical charts of patients diagnosed as DM were retrospectively examined. Epidemiological, clinical, laboratory, instrumental, and histological features of the patients at the time of diagnosis were collected. CADM was diagnosed in the presence of DM-like rash without muscular involvement.
Results: A total of 103 DM patients were identified, of these, 8 were diagnosed with CADM. Six of patients with CADM had subclinical muscle involvement, and were therefore classifiable as hypomyopathic DM.
Conclusions: In our case series, CADM represents 7.7% of the total DM. However, if investigated with instrumental methods, most patients with CADM result to have subclinical muscular involvement.
Similar articles
-
A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.J Am Acad Dermatol. 2006 Apr;54(4):597-613. doi: 10.1016/j.jaad.2005.10.041. Epub 2006 Jan 23. J Am Acad Dermatol. 2006. PMID: 16546580 Review.
-
Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy-associated risk factors in a specific tertiary-care-centre cohort.Br J Dermatol. 2016 Jan;174(1):158-64. doi: 10.1111/bjd.14227. Epub 2015 Dec 1. Br J Dermatol. 2016. PMID: 26490490
-
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis.Clin Exp Rheumatol. 2024 Feb;42(2):288-294. doi: 10.55563/clinexprheumatol/kgpnbq. Epub 2024 Mar 14. Clin Exp Rheumatol. 2024. PMID: 38488091
-
Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.J Rheumatol. 2017 Mar;44(3):319-325. doi: 10.3899/jrheum.160682. Epub 2017 Jan 15. J Rheumatol. 2017. PMID: 28089977
-
A systematic review of juvenile-onset clinically amyopathic dermatomyositis.Br J Dermatol. 2007 Oct;157(4):637-44. doi: 10.1111/j.1365-2133.2007.08055.x. Epub 2007 Jun 26. Br J Dermatol. 2007. PMID: 17596148 Review.
Cited by
-
Clinical Characteristics and Management of Patients With Clinical Amyopathic Dermatomyositis: A Retrospective Study of 64 Patients at a Tertiary Dermatology Department.Front Med (Lausanne). 2021 Dec 2;8:783416. doi: 10.3389/fmed.2021.783416. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34926528 Free PMC article.
-
Retrospective Analysis of Cancer-Associated Myositis Patients over the Past 3 Decades in a Hungarian Myositis Cohort.Pathol Oncol Res. 2020 Jul;26(3):1749-1755. doi: 10.1007/s12253-019-00756-4. Epub 2019 Oct 23. Pathol Oncol Res. 2020. PMID: 31646426 Free PMC article.
-
Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.Clin Rheumatol. 2017 Aug;36(8):1919-1926. doi: 10.1007/s10067-017-3671-0. Epub 2017 May 9. Clin Rheumatol. 2017. PMID: 28488124 Review.
-
A Case of Amyopathic Dermatomyositis with Pneumomediastinum and Subcutaneous Emphysema.Case Rep Rheumatol. 2015;2015:813902. doi: 10.1155/2015/813902. Epub 2015 Oct 18. Case Rep Rheumatol. 2015. PMID: 26557403 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
